April 30, 2016 8:13 AM ET

Pharmaceuticals

Company Overview of U3 Pharma GmbH

Company Overview

U3 Pharma GmbH, a clinical-stage biopharmaceutical company, develops protein therapeutics for the treatment of cancer. The company’s drug development pipeline comprises antibodies and antibody-drug-conjugates. Its medicines are directed against cancer but selected drugs also have potential for treating cardiovascular or metabolic diseases. The company was founded in 2001 and is based in Martinsried, Germany. As of June 19, 2008, U3 Pharma GmbH operates as a subsidiary of Daiichi Sankyo Company, Limited.

Fraunhoferstr. 22

Martinsried,  82152

Germany

Founded in 2001

Phone:

49 89 8103 9100

Fax:

49 89 8103 9199

Key Executives for U3 Pharma GmbH

Co-Founder, Chief Executive Officer and Member of Board of Management
Scientific Founder and Director
Age: 71
Co-Founder and Director of R&D
Co-Founder and Director of R&D
Co-Founder and Director of R&D
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Merz GmbH & Co. KGaA Europe
Boehringer Ingelheim Vetmedica Gmbh Europe
Pfizer Consumer Healthcare GmbH Europe
E. Merck KG Europe
LipoNova AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact U3 Pharma GmbH, please visit www.u3pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.